AKYA(Delisted)
Akoya Biosciences·NASDAQ
--
--(--)
AKYA fundamentals
Akoya Biosciences (AKYA) released its earnings on May 18, 2021: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
May 18, 2021
EPS
Revenue
Revenue & Expenses
AKYA has released its 2025 Q1 earnings report, with revenue of 16.64M, reflecting a YoY change of -9.32%, and net profit of -15.65M, showing a YoY change of 33.35%. The Sankey diagram below clearly presents AKYA's revenue sources and cost distribution.
Key Indicators
Akoya Biosciences (AKYA) key financial stats and ratios, covering profitability, financial health, and leverage.
Akoya Biosciences (AKYA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Akoya Biosciences (AKYA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Akoya Biosciences (AKYA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Akoya Biosciences (AKYA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Akoya Biosciences (AKYA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
